Dr. Uwe GOTTSCHALK

OPERATING PARTNER

Dr. Uwe Gottschalk is an Operating Partner at Keensight Capital.

Uwe has more than 30 years of experience within the field of bioprocessing and enzyme purification technologies.

He was CSO (Chief Scientific Officer) and CTO (Chief Technical Officer) of Lonza Pharma, a world leader in Life Sciences headquartered in Switzerland, from 2014 to 2021, where he focused on downstream bioprocesses.

Prior to Lonza, he was successively Vice President in Purification Technologies (2001-2009) and Group Vice President (2009-2014) of Sartorius, a leading international partner of life science research and the biopharmaceutical industry, listed on the German DAX stock market.

A German national, Uwe holds a Ph.D in Chemistry from the University of Münster.